Pressure BioSciences Raises $1M in Private Placement | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences has raised $1 million of a targeted $1.5 million in a private placement of units consisting of convertible preferred stock and warrants to purchase common stock.

In this first tranche of the placement, Pressure Bio sold an aggregate of 4,000 units at a purchase price of $250 per unit. The investors included existing investors in the firm and members of the company's board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."